Shoulson I, Asbury A, McKhann GM, McDonald I (1986) Huntington’s Disease: The disease of the nervous system. Ardmore Medical Books (W. B. Saunders): Philadephia

Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC (2004) Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem Res 29(4):741–746PubMed

The Huntington’s Collaborative Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983

Koutouzis TK, Emerich D, Borlongan CV, Freeman TB, Cahill DW, Sanberg PR (1991) Cell transplantation for central nervous system disorders. CRC Crit Rev Neurobiol 3:25–162

Zorumski CF, Olney JW (1993) Excitotoxic neuronal damage and neuropsychiatric disorders. J Pharm Ther 59:145–162

Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypothesis. Neurol 42:733–738

Ankarcrona M, Dypbukt JM. Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961–973

Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31:119–130PubMed

Cox JA, Lysko PG, Henneberry RC (1989) Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: role of the voltage-dependent magnesium block. Brain Res 499:267–272PubMed

Novelli A, Reilly LA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energies are reduced. Brain Res 451:205–212PubMed

Koroshetz WJ, Jenkins BG, Beal MF, Rosen BR (1992) Localized proton-NMR spectroscopy in patients with Huntington’s disease (HD) demonstrates abnormal lactate levels in occipital cortex: evidence for compromised metabolism in HD. Neurology 42:319

Sanberg PR, Coyle JT (1984) Scientific approaches to Huntington’s disease. CRC Crit Rev Clin Neurobiol 1:1–44PubMed

Hantraye P, Riche D, Maziere M, Isacson O (1990) A primate model of Huntington’s disease: behavioural and anatomical studies of unilateral excitotoxic lesions of the caudate-putaman in the baboon. Exp Neurol 108:91–104PubMed

Isacson O, Brundin P, Gage FH, Bjorkland A (1985) Neural grafting in the rat model of Huntington’s disease: progressive neuro-chemical changes after neostriatal ibotenate lesions and tissue grafting. Neurosci 16:799–817

Beal MF, Broulillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Strivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181–4182PubMed

Ludolph AC, He F, Spencer PF, Hammerstad J, Sabri M (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492–498PubMed

Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Strivastava R, Roy DS, Rosen BR, Beal MF (1993) Age dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neutochem 60:356–359

Nishino H, Shimano Y, Kumazaki M, Sakurai T (1995) Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier. Neurosci Lett 186:161–164PubMed

Shimano Y, Kumazaki M, Sakurai T, Hida H, Fujimoto I, Fukuda A, Nishino H (1995) Chronically administered 3-nitropropionic acid produces selective lesions in the striatum and reduces muscle tonus. Obesity Res 3:779–784

Hamilton BF, Gould DH (1987) Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 72:286–297PubMed

Bossi SR, Simpson JR, Isacson O (1993) Age dependence of striatal neuronal death caused by mitochondrial dysfunction. Neuroreport 4:73–76PubMed

Borlongan CV, Koutouzis TK, Cahill DW, Freeman TB, Sanberg PR (1995) Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in rats. Brain Res Bull 36:549–556PubMed

Koutouzis TK, Borlongan CV, Scorcia T, Creese, I, Cahill DW, Freeman T B, Sanberg PR (1994) Systemic 3-nitropropionic acid: long effects on locomotor behavior. Brain Res Rev 64:242–244

Filloux F, Wagster MV, Folstein S, Price DL, Hedreen JC, Dawson TM, Wamsley JK (1990) Nigral dopamine type-1 are reduced in Huntington’s disease: a postmortem autoradiographic study using the [3H] SCH23390 and correlation with [3H] forskolin binding. Exp Neurol 110:219–227PubMed

Gould DH, Gustine DL (1982) Basal ganglia degeneration, myelin alterations, and enzyme inhibition in mice induced by the plant toxin 3- nitropropionic acid. Neuropathol Appl Neurobiol 8:377–393PubMed

Zorumski CF, Olney JW (1993) Excitotoxic neuronal damage and neuropsychiatric disorders. J Pharm Ther 59:145–162

Borlongan CV, Koutouzis TK, Cahill DW, Freeman TB, Sanberg PR (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington’s disease. Brain Res 697:254–257PubMed

Bruyn GW (1968) Huntington’s chorea, historical, clinical and laboratory synopsis. Handbook Clin Neurol 6:298–378

Brouillet E, Hantraye P, Dolan R, Leroy-Willig A, Bottlaender M. Isacson O, Maziere M, Ferrante RJ, Beal MF (1993) Soc Neurosci Absa 19:409

Koutouzis TK, Borlongan CV, Cahill DW, Freeman TB, Sanberg PR (1994) Intrastriatal 3-nitropropionic acid: a behavioral assessment. Neuroreport 5:2241–2245PubMed

Mettler, FA (1972) Choreoathetosis and striopallidonigral necrosis due to sodium azide. Exp. Neurol. 34:291–308PubMed

Stober T, Wussow W, Schimrigk K (1984) Bicaudate diameter – the most specific and simplified CT parameter in the diagnosis of Huntington’s disease. Neuroradiol 26:25–28

Almeida S, Domingues A, Rodrigues L, Oliveira CR, Rego AC (2004) FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol Dis 17(3):435–444PubMed

Luchowska E, Luchowski P, Wielosz M, Turski WA, Urbanska EM (2003) FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices. Acta Neurobiol Exp (Wars) 63(2):101–108

Maciel EN, Kowaltowski AJ, Schwalm FD, Rodrigues JM, Souza DO, Vercesi AE, Wajner M, Castilho RF (2004) Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition. J Neurochem 90(5):1025–1035PubMed

Keller JN, Guo Q, Holtsberg FW, Bruce-Keller AJ, Mattson MP (1998) Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 18(12):4439–4450PubMed

Mao Z, Choo YS, Lesort M (2006) Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington’s disease knock0in striatal cells. Eur J Neurosci 23(7):1701–1710PubMed

Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, Kushnareva YE, et al. (2005) Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J Biol Chem 280(49):40398–40401PubMed

Wu CL, Chen SD, Yin JH, Hwang CS, Yang DI (2010) Erythropoietin and sonic hedgehog mediate the neurotrophic factor against mitochondrial inhibition. Neurobiol Dis 40(1):146–154PubMed

Calkins MJ, Townsend JA, Johnson DA, Johnson JA (2010) Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Exp Neurol 224(1):307–317PubMed

Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P, Murphy TH (2005) Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280(24):22925–22936PubMed

Wang L, Ankati H, Akubathini SK, Balderamos M, Storey CA, Patel AV, Price V, Kretzschmar D, Biehl ER, D’Mello SR (2010) Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration. J Neurosci Res 88(9):1970–1984PubMed

Tantucci M, Mariucci G, Taha E, Spaccatini C, Tozzi A, Luchetti E, Calabresi P, Ambrosini MV (2009) Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment. Neuroscience 163(3):735–740PubMed